Cancer Research Meeting Calendar Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 71-73, January 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, I. H. N.
Right arrow Articles by Johnson, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, I. H. N.
Right arrow Articles by Johnson, P. J.
[Cancer Research 59, 71-73, January 1, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients1

Ivy H. N. Wong, Y. M. Dennis Lo2, Jun Zhang, Choong-Tsek Liew, Margaret H. L. Ng, Nathalie Wong, Paul B. S. Lai, Wan Y. Lau, N. Magnus Hjelm and Philip J. Johnson

Departments of Anatomical and Cellular Pathology [I. H. N. W., C-T. L., M. H. L. N.], Chemical Pathology [Y. M. D. L., J. Z., N. M. H.], Clinical Oncology and the Sir Y. K. Pao Cancer Center [N. W., P. J. J.], Surgery [P. B. S. L., W. Y. L.], The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR

We have studied the feasibility of detecting tumor-associated aberrant p16 methylation in the circulation of patients with hepatocellular carcinoma (HCC). We extracted DNA from the tumor tissues and peripheral blood plasma or serum of 22 HCC patients. p16 methylation was found in 73% (16 of 22) of HCC tissues using methylation-specific PCR. Among the 16 cases with aberrant methylation in the tumor tissues, similar changes were also detected in the plasma/serum samples of 81% (13 of 16) of the cases. No methylated p16 sequences were detected in the peripheral plasma/serum of the six HCC cases without these changes in the tumor, in 38 patients with chronic hepatitis/cirrhosis, or in 10 healthy control subjects. These results suggest that circulating liver tumor DNA may be detected using tumor-associated DNA methylation changes. Because methylation abnormalities have been found in many other genes and tumor types, this approach may have implications for the noninvasive detection of a wide variety of cancers.




This article has been cited by other articles:


Home page
 Clin. Chem.Home page
T. deVos, R. Tetzner, F. Model, G. Weiss, M. Schuster, J. Distler, K. V. Steiger, R. Grutzmann, C. Pilarsky, J. K. Habermann, et al.
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
Clin. Chem., July 1, 2009; 55(7): 1337 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. M. Shekhtman, K. Anne, H. S. Melkonyan, D. J. Robbins, S. L. Warsof, and S. R. Umansky
Optimization of Transrenal DNA Analysis: Detection of Fetal DNA in Maternal Urine
Clin. Chem., April 1, 2009; 55(4): 723 - 729.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K.C. A. Chan, S.-F. Leung, S.-W. Yeung, A. T.C. Chan, and Y.M. D. Lo
Persistent Aberrations in Circulating DNA Integrity after Radiotherapy Are Associated with Poor Prognosis in Nasopharyngeal Carcinoma Patients
Clin. Cancer Res., July 1, 2008; 14(13): 4141 - 4145.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. J. Bastian, G. S. Palapattu, S. Yegnasubramanian, X. Lin, C. G. Rogers, L. A. Mangold, B. Trock, M. Eisenberger, A. W. Partin, and W. G. Nelson
Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy
Clin. Cancer Res., September 15, 2007; 13(18): 5361 - 5367.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. G. Chen, S. Y. Kuang, P. A. Egner, J. H. Lu, Y. R. Zhu, J. B. Wang, B. C. Zhang, T. Y. Chen, A. Munoz, T. W. Kensler, et al.
Acceleration to Death from Liver Cancer in People with Hepatitis B Viral Mutations Detected in Plasma by Mass Spectrometry
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1213 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. G. Rivenbark and W. B. Coleman
The Use of Epigenetic Biomarkers for Preclinical Detection of Hepatocellular Carcinoma: Potential for Noninvasive Screening of High-Risk Populations
Clin. Cancer Res., April 15, 2007; 13(8): 2309 - 2312.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-J. Zhang, H.-C. Wu, J. Shen, H. Ahsan, W. Y. Tsai, H.-I Yang, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
Clin. Cancer Res., April 15, 2007; 13(8): 2378 - 2384.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. O. Hoque, Q. Feng, P. Toure, A. Dem, C. W. Critchlow, S. E. Hawes, T. Wood, C. Jeronimo, E. Rosenbaum, J. Stern, et al.
Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast Cancer
J. Clin. Oncol., September 10, 2006; 24(26): 4262 - 4269.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Hagiwara, L. E. Mechanic, G. E. Trivers, H. L. Cawley, M. Taga, E. D. Bowman, K. Kumamoto, P. He, M. Bernard, S. Doja, et al.
Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco Smokers
Cancer Res., August 15, 2006; 66(16): 8309 - 8317.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. H. Tang, D. H. Yang, W. Huang, H. K. Zhou, X. H. Lu, and G. Ye
Hypomethylated P4 Promoter Induces Expression of the Insulin-Like Growth Factor-II Gene in Hepatocellular Carcinoma in a Chinese Population.
Clin. Cancer Res., July 15, 2006; 12(14): 4171 - 4177.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. V. Brock, C. M. Hooker, R. Yung, M. Guo, Y. Han, S. E. Ames, D. Chang, S. C. Yang, D. Mason, M. Sussman, et al.
Can We Improve the Cytologic Examination of Malignant Pleural Effusions Using Molecular Analysis?
Ann. Thorac. Surg., October 1, 2005; 80(4): 1241 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Liu, L.-E Wang, L. Wang, K. H. Lu, G. B. Mills, M. L. Bondy, and Q. Wei
Methylation and Messenger RNA Expression of p15INK4b but Not p16INK4a Are Independent Risk Factors for Ovarian Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4968 - 4976.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Miyamoto and T. Ushijima
Diagnostic and Therapeutic Applications of Epigenetics
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S.-Y. Kuang, S. Lekawanvijit, N. Maneekarn, S. Thongsawat, K. Brodovicz, K. Nelson, and J. D. Groopman
Hepatitis B 1762T/1764A Mutations, Hepatitis C Infection, and Codon 249 p53 Mutations in Hepatocellular Carcinomas from Thailand
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 380 - 384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. C. H. Yu, D. Y. M. Lo, C. B. Ip, C. T. Liew, T. W. T. Leung, and W. Y. Lau
Does Percutaneous Liver Biopsy of Hepatocellular Carcinoma Cause Hematogenous Dissemination? An In Vivo Study with Quantitative Assay of Circulating Tumor DNA Using Methylation-Specific Real-Time Polymerase Chain Reaction
Am. J. Roentgenol., August 1, 2004; 183(2): 383 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. W. Park, R. S. Kerbel, G. J. Kelloff, J. C. Barrett, B. A. Chabner, D. R. Parkinson, J. Peck, R. W. Ruddon, C. C. Sigman, and D. J. Slamon
Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development
Clin. Cancer Res., June 1, 2004; 10(11): 3885 - 3896.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. F. V. Woude, G. J. Kelloff, R. W. Ruddon, H.-M. Koo, C. C. Sigman, J. C. Barrett, R. W. Day, A. P. Dicker, R. S. Kerbel, D. R. Parkinson, et al.
Reanalysis of Cancer Drugs: Old Drugs, New Tricks
Clin. Cancer Res., June 1, 2004; 10(11): 3897 - 3907.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
Y.-H. Su, M. Wang, D. E. Brenner, A. Ng, H. Melkonyan, S. Umansky, S. Syngal, and T. M. Block
Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
J. Mol. Diagn., May 1, 2004; 6(2): 101 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-Y. Kuang, P. E. Jackson, J.-B. Wang, P.-X. Lu, A. Munoz, G.-S. Qian, T. W. Kensler, and J. D. Groopman
Specific mutations of hepatitis B virus in plasma predict liver cancer development
PNAS, March 9, 2004; 101(10): 3575 - 3580.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. H. N. Wong, J. Chan, J. Wong, and P. K. H. Tam
Ubiquitous Aberrant RASSF1A Promoter Methylation in Childhood Neoplasia1
Clin. Cancer Res., February 1, 2004; 10(3): 994 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Widschwendter, H. M. Muller, H. Fiegl, L. Ivarsson, A. Wiedemair, E. Muller-Holzner, G. Goebel, C. Marth, and M. Widschwendter
DNA Methylation in Serum and Tumors of Cervical Cancer Patients
Clin. Cancer Res., January 15, 2004; 10(2): 565 - 571.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. E. Cottrell, J. Distler, N. S. Goodman, S. H. Mooney, A. Kluth, A. Olek, I. Schwope, R. Tetzner, H. Ziebarth, and K. Berlin
A real-time PCR assay for DNA-methylation using methylation-specific blockers
Nucleic Acids Res., January 13, 2004; 32(1): e10 - e10.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Liu, Q. An, L. Li, D. Zhang, J. Huang, X. Feng, S. Cheng, and Y. Gao
Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications
Carcinogenesis, December 1, 2003; 24(12): 1897 - 1901.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. G. Herman and S. B. Baylin
Gene Silencing in Cancer in Association with Promoter Hypermethylation
N. Engl. J. Med., November 20, 2003; 349(21): 2042 - 2054.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
H. M. Muller, A. Widschwendter, H. Fiegl, L. Ivarsson, G. Goebel, E. Perkmann, C. Marth, and M. Widschwendter
DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker
Cancer Res., November 15, 2003; 63(22): 7641 - 7645.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. E. Jackson, S.-Y. Kuang, J.-B. Wang, P. T. Strickland, A. Munoz, T. W. Kensler, G.-S. Qian, and J. D. Groopman
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
Carcinogenesis, October 1, 2003; 24(10): 1657 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. K. Vanaja, J. C. Cheville, S. J. Iturria, and C. Y. F. Young
Transcriptional Silencing of Zinc Finger Protein 185 Identified by Expression Profiling Is Associated with Prostate Cancer Progression
Cancer Res., July 15, 2003; 63(14): 3877 - 3882.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Mol. Pathol., June 1, 2003; 56(3): 172 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. W. Chang, A. Chan, D. L. W. Kwong, W. I. Wei, J. S. T. Sham, and A. P. W. Yuen
Detection of Hypermethylated RIZ1 Gene in Primary Tumor, Mouth, and Throat Rinsing Fluid, Nasopharyngeal Swab, and Peripheral Blood of Nasopharyngeal Carcinoma Patient
Clin. Cancer Res., March 1, 2003; 9(3): 1033 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. H. N. Wong, J. Zhang, P. B. S. Lai, W. Y. Lau, and Y. M. Dennis Lo
Quantitative Analysis of Tumor-derived Methylated p16INK4a Sequences in Plasma, Serum, and Blood Cells of Hepatocellular Carcinoma Patients
Clin. Cancer Res., March 1, 2003; 9(3): 1047 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher
A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
Gut, January 1, 2003; 52(1): 101 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G.-S. Qian, S.-Y. Kuang, X. He, J. D. Groopman, and P. E. Jackson
Sensitivity of Electrospray Ionization Mass Spectrometry Detection of Codon 249 Mutations in the p53 Gene Compared with RFLP
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1126 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
O. Okochi, K. Hibi, T. Uemura, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao
Detection of Mitochondrial DNA Alterations in the Serum of Hepatocellular Carcinoma Patients
Clin. Cancer Res., September 1, 2002; 8(9): 2875 - 2878.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. J. Johnson and Y.M. D. Lo
Plasma Nucleic Acids in the Diagnosis and Management of Malignant Disease
Clin. Chem., August 1, 2002; 48(8): 1186 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Bakker, X. Lin, and W. G. Nelson
Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated pi -Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells
J. Biol. Chem., June 14, 2002; 277(25): 22573 - 22580.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T.-L. Lee, W. K. Leung, M. W. Y. Chan, E. K. W. Ng, J. H. M. Tong, K.-W. Lo, S. C. S. Chung, J. J. Y. Sung, and K.-F. To
Detection of Gene Promoter Hypermethylation in the Tumor and Serum of Patients with Gastric Carcinoma
Clin. Cancer Res., June 1, 2002; 8(6): 1761 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Shen, N. Ahuja, Y. Shen, N. A. Habib, M. Toyota, A. Rashid, and J.-P. J. Issa
DNA Methylation and Environmental Exposures in Human Hepatocellular Carcinoma
J Natl Cancer Inst, May 15, 2002; 94(10): 755 - 761.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Dominguez, J. Carballido, J. Silva, J. M. Silva, J. M. Garcia, J. Menendez, M. Provencio, P. Espana, and F. Bonilla
p14ARF Promoter Hypermethylation in Plasma DNA as an Indicator of Disease Recurrence in Bladder Cancer Patients
Clin. Cancer Res., April 1, 2002; 8(4): 980 - 985.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Zhong, M. W. Tang, W. Yeo, C. Liu, Y. M. D. Lo, and P. J. Johnson
Silencing of GSTP1 Gene by CpG Island DNA Hypermethylation in HBV-associated Hepatocellular Carcinomas
Clin. Cancer Res., April 1, 2002; 8(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Sze Wong, H. Wen Chang, K. Chi Tang, W. Ignace Wei, D. Lai Wen Kwong, J. Shun Tong Sham, A. Po Wing Yuen, and Y. Lam Kwong
High Frequency of Promoter Hypermethylation of the Death-associated Protein-Kinase Gene in Nasopharyngeal Carcinoma and Its Detection in the Peripheral Blood of Patients
Clin. Cancer Res., February 1, 2002; 8(2): 433 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
U. Lehmann, F. Langer, H. Feist, S. Glockner, B. Hasemeier, and H. Kreipe
Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
Am. J. Pathol., February 1, 2002; 160(2): 605 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H.-Z. Zou, B.-M. Yu, Z.-W. Wang, J.-Y. Sun, H. Cang, F. Gao, D. H. Li, R. Zhao, G.-G. Feng, and J. Yi
Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients
Clin. Cancer Res., January 1, 2002; 8(1): 188 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Silva, F. Bonilla, H. Blons, F. Coulet, and P. Laurent-Puig
Correspondence re: F. Coulet et al., Detection of Plasma Tumor DNA in Head and Neck Squamous Cell Carcinoma by Microsatellite Typing and p53 Mutation Analysis. Cancer Res., 60: 707-709, 2000.
Cancer Res., December 1, 2001; 61(23): 8595 - 8596.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Hibi, M. Taguchi, H. Nakayama, T. Takase, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao
Molecular Detection of p16 Promoter Methylation in the Serum of Patients with Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., October 1, 2001; 7(10): 3135 - 3138.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Cairns, M. Esteller, J. G. Herman, M. Schoenberg, C. Jeronimo, M. Sanchez-Cespedes, N.-H. Chow, M. Grasso, L. Wu, W. B. Westra, et al.
Molecular Detection of Prostate Cancer in Urine by GSTP1 Hypermethylation
Clin. Cancer Res., September 1, 2001; 7(9): 2727 - 2730.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. H. L. Ng, K. W. To, K. W. Lo, S. Chan, K. S. Tsang, S. H. Cheng, and H. K. Ng
Frequent Death-associated Protein Kinase Promoter Hypermethylation in Multiple Myeloma
Clin. Cancer Res., June 1, 2001; 7(6): 1724 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. B. Baylin, M. Esteller, M. R. Rountree, K. E. Bachman, K. Schuebel, and J. G. Herman
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Hum. Mol. Genet., April 1, 2001; 10(7): 687 - 692.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. C. Pulling, D. M. Klinge, and S. A. Belinsky
p16INK4a and {beta}-catenin alterations in rat liver tumors induced by NNK
Carcinogenesis, March 1, 2001; 22(3): 461 - 466.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H Kaneto, S Sasaki, H Yamamoto, F Itoh, M Toyota, H Suzuki, I Ozeki, N Iwata, T Ohmura, T Satoh, et al.
Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus
Gut, March 1, 2001; 48(3): 372 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Strathdee, K. Appleton, M. Illand, D. W. M. Millan, J. Sargent, J. Paul, and R. Brown
Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes
Am. J. Pathol., March 1, 2001; 158(3): 1121 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. M. Grady, A. Rajput, J. D. Lutterbaugh, and S. D. Markowitz
Detection of Aberrantly Methylated hMLH1 Promoter DNA in the Serum of Patients with Microsatellite Unstable Colon Cancer
Cancer Res., February 1, 2001; 61(3): 900 - 902.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. L. B. Rosas, W. Koch, M. d. G. d. C. Carvalho, L. Wu, J. Califano, W. Westra, J. Jen, and D. Sidransky
Promoter Hypermethylation Patterns of p16, O6-Methylguanine-DNA-methyltransferase, and Death-associated Protein Kinase in Tumors and Saliva of Head and Neck Cancer Patients
Cancer Res., February 1, 2001; 61(3): 939 - 942.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. Jahr, H. Hentze, S. Englisch, D. Hardt, F. O. Fackelmayer, R.-D. Hesch, and R. Knippers
DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells
Cancer Res., February 1, 2001; 61(4): 1659 - 1665.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
Y. M. D. Lo, A. T. C. Chan, L. Y. S. Chan, S.-F. Leung, C.-W. Lam, D. P. Huang, and P. J. Johnson
Molecular Prognostication of Nasopharyngeal Carcinoma by Quantitative Analysis of Circulating Epstein-Barr Virus DNA
Cancer Res., December 1, 2000; 60(24): 6878 - 6881.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
Y.M. D. Lo
Fetal DNA in Maternal Plasma: Biology and Diagnostic Applications
Clin. Chem., December 1, 2000; 46(12): 1903 - 1906.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. D. Davis, E. O. Uthus, and J. W. Finley
Dietary Selenium and Arsenic Affect DNA Methylation In Vitro in Caco-2 Cells and In Vivo in Rat Liver and Colon
J. Nutr., December 1, 2000; 130(12): 2903 - 2909.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Goessl, H. Krause, M. Müller, R. Heicappell, M. Schrader, J. Sachsinger, and K. Miller
Fluorescent Methylation-specific Polymerase Chain Reaction for DNA-based Detection of Prostate Cancer in Bodily Fluids
Cancer Res., November 1, 2000; 60(21): 5941 - 5945.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
I. H.N. Wong, Y.M. D. Lo, P. B.S. Lai, and P. J. Johnson
Relationship of p16 Methylation Status and Serum {alpha}-Fetoprotein Concentration in Hepatocellular Carcinoma Patients
Clin. Chem., September 1, 2000; 46(9): 1420 - 1422.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. H. N. Wong, Y. M. Dennis Lo, W. Yeo, W. Y. Lau, and P. J. Johnson
Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients
Clin. Cancer Res., September 1, 2000; 6(9): 3516 - 3521.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
I. Botezatu, O.'g. Serdyuk, G. Potapova, V. Shelepov, R. Alechina, Y. Molyaka, V. Anan'ev, I. Bazin, A. Garin, M. Narimanov, et al.
Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism
Clin. Chem., August 1, 2000; 46(8): 1078 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. H. N. Wong, A. T. Chan, and P. J. Johnson
Quantitative Analysis of Circulating Tumor Cells in Peripheral Blood of Osteosarcoma Patients Using Osteoblast-specific Messenger RNA Markers: A Pilot Study
Clin. Cancer Res., June 1, 2000; 6(6): 2183 - 2188.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
A. V. Todd, C. J. Fuery, H. L. Impey, T. L. Applegate, and M. A. Haughton
DzyNA-PCR: Use of DNAzymes to Detect and Quantify Nucleic Acid Sequences in a Real-Time Fluorescent Format
Clin. Chem., May 1, 2000; 46(5): 625 - 630.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. H. N. Wong, M. H. L. Ng, D. P. Huang, and J. C. K. Lee
Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications
Blood, March 15, 2000; 95(6): 1942 - 1949.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Coulet, H. Blons, A. Cabelguenne, T. Lecomte, O. Laccourreye, D. Brasnu, P. Beaune, J. Zucman, and P. Laurent-Puig
Detection of Plasma Tumor DNA in Head and Neck Squamous Cell Carcinoma by Microsatellite Typing and p53 Mutation Analysis
Cancer Res., February 1, 2000; 60(3): 707 - 711.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Sanchez-Cespedes, M. Esteller, L. Wu, H. Nawroz-Danish, G. H. Yoo, W. M. Koch, J. Jen, J. G. Herman, and D. Sidransky
Gene Promoter Hypermethylation in Tumors and Serum of Head and Neck Cancer Patients
Cancer Res., February 1, 2000; 60(4): 892 - 895.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
G. D. Kirk, A.-M. Camus-Randon, M. Mendy, J. J. Goedert, P. Merle, C. Trepo, C. Brechot, P. Hainaut, and R. Montesano
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
J Natl Cancer Inst, January 19, 2000; 92(2): 148 - 153.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. q. Chen, H. Bonnefoi, S. Diebold-Berger, J. Lyautey, C. Lederrey, E. Faltin-Traub, M. Stroun, and P. Anker
Detecting Tumor-related Alterations in Plasma or Serum DNA of Patients Diagnosed with Breast Cancer
Clin. Cancer Res., September 1, 1999; 5(9): 2297 - 2303.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. M. D. Lo, I. H. N. Wong, J. Zhang, M. S. C. Tein, M. H. L. Ng, and N. M. Hjelm
Quantitative Analysis of Aberrant p16 Methylation Using Real-Time Quantitative Methylation-specific Polymerase Chain Reaction
Cancer Res., August 1, 1999; 59(16): 3899 - 3903.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Silva, G. Dominguez, J. M. Garcia, R. Gonzalez, M. J. Villanueva, F. Navarro, M. Provencio, S. San Martin, P. Espana, and F. Bonilla
Presence of Tumor DNA in Plasma of Breast Cancer Patients: Clinicopathological Correlations
Cancer Res., July 1, 1999; 59(13): 3251 - 3256.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.